The Tufts Center for the Study of Drug Development recently estimated that the average cost to develop a new drug and gain market approval now approaches $2.6 billion, with the largest portion of that sum attributed to clinical trials. A separate study by KPMG asserted that the return on investment ...
Delivered by KPMG Today (@KPMG_TO)
Article continues here
Follow @KPMG_TO on Twitter to get latest updates
